“Biotech Mergers: Evaluating Risk, Reporting, and Integration of Growth Strategies : Gilead’s Acquisition of Immunomedics: Risk and a Growth Strategy ” (2025) The Accounting Educators’ Journal, 33. Available at: https://aejournal.com/ojs/index.php/aej/article/view/1044 (Accessed: 12 October 2026).